Expertise in the production of lyophilized drugs at Cenexi

The latest edition of Pharmaceutical Post, a magazine specialized in the pharmaceutical industry, dedicates a special report to the new challenges of lyophilization.

In this context, a long interview with Jérôme Keldenich, MSAT (Manufacturing Science and Technology) Director is dedicated to explain the specificities of the production of lyophilized drugs.

Indeed, “our Braine-l’Alleud site has 15 years of experience in the development of lyophilized forms and their transfer to commercial production lines, and more than 20 years of experience in commercial production of these same forms.”

From big pharma to innovative biotechs, this represents more than 80 % of the volumes produced within our Belgian site, thanks to the 6 freeze-dryers located there.

Autres actualités